Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space.

Saved in:
Bibliographic Details
Title: Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space.
Authors: Jelwan Y; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Cao T; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA.; Johns Hopkins Bloomberg School of Public Health Baltimore MD USA., Yao Z; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Burka S; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Erhabor J; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Berning P; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Dzaye O; University of Texas Southwestern Medical Center Dallas TX USA., Blaha M; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA.
Source: Journal of the American Heart Association [J Am Heart Assoc] 2026 Jun 16; Vol. 15 (12), pp. e046837. Date of Electronic Publication: 2026 Jun 09.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2047-9980
DOI:10.1161/JAHA.125.046837